Downregulation of microRNA-214 and PTEN in tissue samples of patients with breast cancer
Downregulation of microRNA-214 and PTEN in tissue samples of patients with breast cancer
نویسندگان: بهمن یوسفی , نیلوفر ترغازه , مهدی یوسفی , میلاد بسطامی , حسین صمدی کفیل , سید مصطفی میر , صونا رفیعیان , انصار کریمیان
کلمات کلیدی: Breast cancer,Tumor tissue, PTEN, miR-214
نشریه: 36918 , 1 , 24 , 2020
| نویسنده ثبت کننده مقاله |
بهمن یوسفی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات کاربردی دارویی |
| کد مقاله |
71399 |
| عنوان فارسی مقاله |
Downregulation of microRNA-214 and PTEN in tissue samples of patients with breast cancer |
| عنوان لاتین مقاله |
Downregulation of microRNA-214 and PTEN in tissue samples of patients with breast cancer |
| ناشر |
13 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: MicroRNAs (miRNAs) are a large group of small non-coding RNAs with critical functions in the
regulation of important genes involved in cellular proliferation and apoptosis, at post-transcription level.
Phosphatase and tensin homolog (PTEN) is a best example of miRNAs target genes. In the present study, we
aimed to evaluate the expression levels of miR-214 and PTEN in tumor tissues and adjacent normal tissues in
patients with breast cancer.
Methods: The expression levels of miR-214 and PTEN were measured in tumor tissue and compared to adjacent
normal cells in 42 patients with breast cancer by qRT-PCR. Statistical analysis was processed using SPSS 21.0,
GraphPad 7.00 software or the Student's t-test. All data from at least three separate experiments are presented.
Results: We found a significant downregulation of miR-214 expression levels in tumor tissues in comparison to
normal tissues (0.85 ± 0.45 vs. 9.59 ± 1.71; P < .001). In addition, the expression levels of PTEN was also
significantly lower in tumor tissues, as compared to adjacent normal tissues (0.75 ± 0.44 vs. 22.72 ± 6.76;
P < .001). There was also a significant correlation between miR-214 and PTEN expression and clinicopathological
factors including age, tumor size, and cancer grade (P < .001).
Conclusion: These findings suggest that miR-214 and PTEN have tumor-suppressor activity and thus, pharmaceutical
interventions targeting miR-124 and PTEN may provide a promising therapeutic strategy for the
treatment of breast cancer. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 10.1016@j.mgene.2020.100668.pdf | 1398/12/24 | 464839 | دانلود |